Business Description
Pangen Biotech Inc
ISIN : KR7222110009
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.4 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | -2.51 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.4 | |||||
Beneish M-Score | -2.28 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.1 | |||||
3-Year EBITDA Growth Rate | -10.1 | |||||
3-Year EPS without NRI Growth Rate | 2.9 | |||||
3-Year FCF Growth Rate | 13.3 | |||||
3-Year Book Growth Rate | -7.2 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 59.92 | |||||
9-Day RSI | 60.48 | |||||
14-Day RSI | 59.78 | |||||
6-1 Month Momentum % | -29.74 | |||||
12-1 Month Momentum % | -30.93 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.61 | |||||
Quick Ratio | 1.28 | |||||
Cash Ratio | 0.91 | |||||
Days Inventory | 313.14 | |||||
Days Sales Outstanding | 61.94 | |||||
Days Payable | 12.11 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.5 | |||||
Shareholder Yield % | -10.76 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 24.54 | |||||
Operating Margin % | -22.79 | |||||
Net Margin % | -25.01 | |||||
FCF Margin % | 3.84 | |||||
ROE % | -18.17 | |||||
ROA % | -12.01 | |||||
ROIC % | -12.66 | |||||
ROC (Joel Greenblatt) % | -20.12 | |||||
ROCE % | -13.55 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.72 | |||||
PB Ratio | 3.26 | |||||
Price-to-Tangible-Book | 4.21 | |||||
Price-to-Free-Cash-Flow | 135.31 | |||||
EV-to-EBIT | -21.48 | |||||
EV-to-EBITDA | -59.36 | |||||
EV-to-Revenue | 4.64 | |||||
EV-to-FCF | 112.15 | |||||
Price-to-Net-Current-Asset-Value | 8.25 | |||||
Earnings Yield (Greenblatt) % | -4.66 | |||||
FCF Yield % | 0.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Pangen Biotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 11,131.732 | ||
EPS (TTM) (â‚©) | -280 | ||
Beta | 0.56 | ||
Volatility % | 44.11 | ||
14-Day RSI | 59.78 | ||
14-Day ATR (â‚©) | 298.405141 | ||
20-Day SMA (â‚©) | 4364.5 | ||
12-1 Month Momentum % | -30.93 | ||
52-Week Range (â‚©) | 3750 - 6920 | ||
Shares Outstanding (Mil) | 11.41 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pangen Biotech Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pangen Biotech Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Pangen Biotech Inc Frequently Asked Questions
What is Pangen Biotech Inc(XKRX:222110)'s stock price today?
When is next earnings date of Pangen Biotech Inc(XKRX:222110)?
Does Pangen Biotech Inc(XKRX:222110) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |